World Journal of Clinical Oncology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Wang G, Liu T, Zhang JX, Li YR, Zhu WJ, Wang JL, Dong WW, Zhang YY, Li YM, Yang LX, He LX, He WT. Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6. World J Clin Oncol 2025; 16(11): 111627 [PMID: 41355910 DOI: 10.5306/wjco.v16.i11.111627]
URL:	https://www.wjgnet.com/2218-4333/full/v16/i11/111627.htm

(26) (36) (0) (0) (0) (12) (775) (1)

Number	Citing Articles
1	Abdellatif Bouayad. Ectonucleoside triphosphate diphosphohydrolase 6: A double-edged sword in cancer prognosis and therapy. World Journal of Clinical Oncology 2025; 16(12): 115789 doi: 10.5306/wjco.v16.i12.115789 Abstract(55) \| Core Tip(55) \| Full Article(HTML)(186) \| Full Article (PDF)-3294K(51) \| Full Article with Cover (PDF)-3580K(19) \| Full Article (XML)-34K(33) \| Audio-229K(10) \| Peer-Review Report-194K(19) \| Answering Reviewers-131K(28) \| Times Cited (0) \| Total Visits (338) \| Open

Number

Citing Articles

Abdellatif Bouayad. Ectonucleoside triphosphate diphosphohydrolase 6: A double-edged sword in cancer prognosis and therapy. World Journal of Clinical Oncology 2025; 16(12): 115789 doi: 10.5306/wjco.v16.i12.115789

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.